"Long protocol" for ovarian stimulation using D-Trp6 LHRH (Triptorelin Depot) and menopausal gonadotropin in the IVF-ET program
Kulikowski, M.; Wołczyński, S.; Grochowski, D.; Kuczyński, W.; Sola, E.; Szamatowicz, J.; Syrewicz, M.; Domitrz, J.; Szamatowicz, M.
Ginekologia Polska 67(5): 243-247
1996
ISSN/ISBN: 0017-0011 PMID: 8925995 Document Number: 467866
39 patients (age 35-40, anovulation, previous failures in the IVF-ET programme) were superovulated using GnRH analogue (Decapeptyl-Depot) in the long protocol and hMG 97 embryos were transferred and 109 were cryopreserved. The clinical pregnancy and implantation rates were 31.6% and 13.4%. The long protocol gives better results in the IVF-ET programme but increases the costs of treatment.
Document emailed within 1 workday
Related Documents
Yang, T.S.; Wang, B.C.; Chang, S.P.; Ng, H.T. 1995: Comparison of human menopausal gonadotropin and follicle-stimulating hormone with gonadotropin-releasing hormone agonist desensitization for controlled ovarian hyperstimulation in in vitro fertilization Zhonghua Yi Xue Za Zhi 55(6): 452-456Haake, K.W.; List, P.; Baier, D.; Zimmermann, G.; Pretzsch, G.; Alexander, H. 1997: Risk assessment in ovarian hyperstimulation syndrome (OHS) using the machine learning system (Decision Master) in 155 in-vitro fertilisations and embryo-transfer (IVF/ET) cycles with a long stimulation protocol Zentralblatt für Gynakologie 119(Suppl 1): 23-27
Cundy, T.; Cornish, J.; Roberts, H.; Reid, I.R. 2002: Menopausal bone loss in long-term users of depot medroxyprogesterone acetate contraception American Journal of Obstetrics and Gynecology 186(5): 978-983
Rossmanith, W.G.; Sterzik, K.; Wolf, A.S. 1987: Initial experiences with subcutaneous pulsatile human menopausal gonadotropin administration: successful induction of ovulation in patients with polycystic ovarian disease International Journal of Fertility 32(6): 460-466
Boschitsch, E.; Gitsch, E.; Spona, J. 1983: Therapy of the surgical menopause syndrome with depot medroxyprogesterone acetate and its objective evaluation testing the reaction of the anterior pituitary gland to stimulation with gonadotropin-releasing hormone Wiener Klinische Wochenschrift 95(20): 718-724
Molo, M.W.; Rawlins, R.G.; Binor, Z.; Kelly, M.; Radwanska, E. 1995: Luteal phase estradiol and pregnancy outcome in gonadotropin releasing hormone agonist/human menopausal gonadotropin-treated gamete intrafallopian transfer cycles Journal of Reproductive Medicine 40(6): 418-422
Olivennes, F.; Righini, C.; Fanchin, R.; Torrisi, C.; Hazout, A.; Glissant, M.; Fernandez, H.; Frydman, R. 1996: Ovarian stimulation using a protocol of low dose agonist in patients with an elevated basal FSH Contraception Fertilite Sexualite 24(12): 912-916
Shastri, S.M.; Barbieri, E.; Kligman, I.; Schoyer, K.D.; Davis, O.K.; Rosenwaks, Z. 2011: Stimulation of the young poor responder: comparison of the luteal estradiol/gonadotropin-releasing hormone antagonist priming protocol versus oral contraceptive microdose leuprolide Fertility and Sterility 95(2): 592-595
Duijkers, I.J.; Willemsen, W.N.; Hollanders, H.M.; Hamilton, C.J.; Thomas, C.M.; Vemer, H.M. 1997: Follicular fluid hormone concentrations after ovarian stimulation using gonadotropin preparations with different FSH/LH ratios. I. Comparison of an FSH-dominant and a purified FSH preparation International Journal of Fertility and Women's Medicine 42(5): 306-310
Conn, P.M.; Rogers, D.; Seay, S. 1984: Gonadotropin releasing hormone stimulation of gonadotropin release from the pituitary regulation of cell responses and gonadotropin releasing hormone receptors by gonadotropin releasing hormone receptor micro aggregation Journal of Cellular Biochemistry Suppl (8 Part A): 233
Fulghesu, A.M.; Lanzone, A.; Guida, C.; Nicoletti, M.C.; Rossi, P.; Le Donne, M.; Caruso, A.; Mancuso, S. 1992: Ovulation induction with human menopausal gonadotropin versus follicle-stimulating hormone after pituitary suppression by gonadotropin releasing hormone agonist in polycystic ovary disease. a cross-over study Journal of Reproductive Medicine 37(10): 834-840
Kumasaka, T.; Masaoka, K.; Watanabe, H.; Mori, T.; Ohya, H.; Tadokoro, N. 1986: Neuroendocrine regulation of LHRH and gonadotropin Advances in Contraceptive Delivery Systems: Cds 2(2-3): 176-181
Park, H.-J.; Koo, Y.-A.; Yoon, B.-K.; Choi, D. 2009: Postoperative long-term maintenance therapy with oral contraceptives after gonadotropin-releasing hormone analog treatment in women with ovarian endometrioma Journal of Minimally Invasive Gynecology 16(1): 34-39
Yang, J.H.; Wu, M.Y.; Chao, K.H.; Chen, S.U.; Ho, H.N.; Yang, Y.S. 1997: Long GnRH-agonist protocol in an IVF program. Is it appropriate for women with normal FSH levels and high FSH/LH ratios? Journal of Reproductive Medicine 42(10): 663-668
Sippell, W.G.; Partsch, C.J.; Hümmelink, R.; Lorenzen, F. 1994: Long-term therapy of true precocious puberty in girls using Decapetyl-Depot, a superactive gonadoliberin agonist in depot microcapsulated form Ceskoslovenska Pediatrie 49(1): 13-18
Toth, T.L.; Awwad, J.T.; Veeck, L.L.; Jones, H.W.; Muasher, S.J. 1996: Suppression and flare regimens of gonadotropin-releasing hormone agonist. Use in women with different basal gonadotropin values in an in vitro fertilization program Journal of Reproductive Medicine 41(5): 321-326
Hempel, E.; Böhm, W.; Möller, R.; Carol, W.; Klinger, G.; Peiker, G. 1975: Use of the depot estrogen ethinylestradiol sulfate in the therapy of menopausal syndrome Zentralblatt für Gynakologie 97(13): 798-810
Wei, Z.; Zhang, L.; Li, M. 1997: Basic ovarian status and follicular response to superovulation stimulation in an in vitro fertilization and embryo transfer program Zhonghua Fu Chan Ke Za Zhi 32(1): 27-30
Kuber, W.; Treu, T.; Kratzik, C.; Girsch, E.; Zeillinger, R.; Spona, J. 1990: Chemical castration using a depot LHRH-agonist as a palliative therapy concept in prostatic carcinoma--clinical, endocrinological and experimental studies Wiener Klinische Wochenschrift 102(21): 640-647
Grabiński, M.; Bolanowski, M.; Zalewski, J.; Zbróg, U. 1987: Successful treatment of female infertility of hypothalamic origin using pulsed administration of gonadotropin-releasing hormone (LHRH) Ginekologia Polska 58(1): 11-16